ST. LOUIS, Nov. 19, 2012 /PRNewswire/ -- Effective
January 1, 2013, Sigma-Aldrich
Corporation (NASDAQ: SIAL) will align its organization into three
market-focused business units that are defined by the customers and
markets they serve. This new organization will enable
Sigma-Aldrich to better address the needs of its global customers
and to further drive global sales growth.
Frank Wicks will transition from
his current role as President of the Research business to become
President of the new Applied Markets Business Unit. This
business unit will serve customers in Diagnostics, Testing and
Industrial markets.
Eric Green will transition from
his current role as Vice President and Managing Director of the
International region (APLA) to become President of the newly
structured Research Markets Business Unit. This business unit
will focus on broadening the offering of research products to
scientists in Life Science, Academic, Government and Hospital
settings around the world. Eric will continue to have
responsibility for the Latin
America region as well.
Gilles Cottier will continue to
lead the SAFC business. This business will be renamed the
SAFC Commercial Markets Business Unit and will continue to serve
customers in the Life Science and Electronic markets.
Gerrit van den Dool will
transition from his current role as Managing Director of the North
American region (United States and
Canada) to become Managing
Director of the European region (EMEA). Gerrit will relocate
to St. Gallen, Switzerland. Jason
Apter will transition from his role of Chief of Staff to
become Managing Director of the Asia
Pacific region and will relocate to Singapore.
Customers in the North American region will be managed directly by
the three business units – Applied Markets, Research Markets and
SAFC Commercial Markets.
Sigma-Aldrich intends to
provide more information about the structure, sales and growth
prospects of each of the three business units early in 2013 in
conjunction with its year-end financial results release.
About Sigma-Aldrich: Sigma-Aldrich is a leading
Life Science and High Technology
company whose biochemical and organic chemical products, kits and
services are used in scientific research, including genomic and
proteomic research, biotechnology, pharmaceutical development, the
diagnosis of disease and as key components in pharmaceutical,
diagnostics and high technology manufacturing. Sigma-Aldrich
customers include more than one million scientists and
technologists in life science companies, university and government
institutions, hospitals and industry. The Company operates in
38 countries and has approximately 9,000 employees whose objective
is to provide excellent service worldwide. Sigma-Aldrich is
committed to accelerating customer success through innovation and
leadership in Life Science, High
Technology and Service. For more
information about Sigma-Aldrich, please visit its website, at
www.sigma-aldrich.com.
SOURCE Sigma-Aldrich Corporation